This manuscript summarizes current thinking on the value and promise of evolving
circulating tumor cell (CTC) technologies for cancer patient diagnosis, prognosis, and …

Epithelial-to-mesenchymal transition (EMT) phenomena endow epithelial cells with
enhanced migratory and invasive potential, and as such, have been implicated in many …

Purpose: The prognostic value of circulating tumor cells (CTC) detected in breast cancer
patients is currently under debate. Different time points of blood collections and various CTC …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Whether circulating tumor cells (CTCs) can be used as an indicator of treatment response in
breast cancer (BC) needs to be clarified. We addressed this issue by a meta-analysis …

Circulating Tumor Cells (CTCs) are shed from primary or secondary tumors into blood
circulation. Accessing and analyzing these cells provides a non-invasive alternative to tissue …

Background Surgery is the treatment of choice for patients with non-small cell lung cancer
(NSCLC) stages I-IIIA. However, more than 20% of these patients develop recurrence and …

Simple Summary Cancer imposes the largest clinical and economic burden, with an
estimated 19.3 million cancer incidents and almost 10.0 million cancer deaths in 2020 …

The major cause of death due to cancer is its metastatic deposit in numerous tissues and
organs. The metastatic process requires the migration of malignant cells from primary sites …

Abstract Blood testing using Circulating Tumor Cells (CTCs) has emerged as one of the
hottest fields in cancer diagnosis. Research on CTCs present nowadays a challenge, as …